Abivax (ABVX) Cash from Financing Activities (2024 - 2026)
Abivax's Cash from Financing Activities came in at -$45.74 million for Q2 2026, compared with -$9.92 million a year earlier.
Powered by 
Analysis
Abivax (ABVX) Cash from Financing Activities (2024 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Abivax reported Cash from Financing Activities of $637.07 billion; for FY2025, it came in at $618.35 billion.
- Cash from Financing Activities carries a four-year compound annual growth rate of 58.6% (FY2021 to FY2025).
- Going back by year, Cash from Financing Activities was $30.53 billion in FY2024 (-91.6%), $362.69 billion in FY2023 (+968.3%), $33.95 billion in FY2022 (-65.3%) and $97.84 billion in FY2021.
- The Q2 2026 figure represents the lowest quarterly Cash from Financing Activities in data going back to Q1 2024.
- Business Quant data shows ABVX's Cash from Financing Activities at $85,464 (Q1 2026), $636.41 billion (Q4 2025) and $705.48 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Abivax | 7.15 Bn | 7.15 Bn | - | -45.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -45.74 Mn |
| Mar 31, 2026 | 85,464.43 |
| Dec 31, 2025 | 636.41 Bn |
| Sep 30, 2025 | 705.48 Mn |
| Jun 30, 2025 | -9.92 Mn |
| Mar 31, 2025 | -8.24 Mn |
| Dec 31, 2024 | 30.11 Bn |
| Sep 30, 2024 | -6.91 Mn |
| Jun 30, 2024 | 20.59 Mn |
| Mar 31, 2024 | 23.03 Mn |
API Access
Abivax Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ABVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "ABVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ABVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();